Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Prevention Research
Cancer Prevention Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Perspective

Strawberry Fields Forever?

Nanjoo Suh and John M. Pezzuto
Nanjoo Suh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John M. Pezzuto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1940-6207.CAPR-11-0534 Published January 2012
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

On the basis of copious preclinical data supporting the preventive efficacy of small fruits such as berries and grapes, Chen and colleagues conducted a randomized (noncomparative) phase II trial evaluating two doses of strawberry powder (60 g/d or 30 g/d for six months) to prevent esophageal cancer in China (reported in this issue of the journal, beginning on page 41); 60 g/d reduced the histologic grade of dysplastic lesions and reduced localized biomarkers, whereas 30 g/d was not effective. Fundamental questions remain such as the best formulation of strawberry powder, the active components associated with powder, and the actual mechanism of action, and standardized preparations will be required to permit the widespread use of strawberry powder with a predicable outcome. Clearly, however, this work is a good example of proof-of-principle and highlights the important role of diet, nutrition, and natural products in cancer prevention. Cancer Prev Res; 5(1); 30–33. ©2012 AACR.

Perspective on Chen et al., p. 41

Cancer is a complex and devastating disease that affects millions of people everyday. Even with recent advances with targeted therapies, it is challenging to treat this disease at late stages. Cancer prevention tries to reverse or prevent the development and progression of early-stage disease before it becomes aggressive and malignant. Because epidemiologic studies suggest the protective effects of small fruits and vegetables against cancer (1–3), consumption of a diet rich in fruit and vegetables, as well as natural product bioactive components, is one strategy to prevent cancer. In recent years, large-scale randomized prevention trials such as the Selenium and Vitamin E Cancer Prevention Trial (SELECT) have shown some disappointing results (4, 5). On the other hand, some hope has been provided by clinical cancer prevention trials of broccoli sprout beverages in Qidong, China (6–8), and of tea catechins to prevent colorectal cancer in Shanghai, China (9, 10), and to prevent oral cancer in the United States (11). Small prevention trials focused on high-risk patients in early stages of carcinogenesis can be meaningful and feasible, as illustrated by the work reported by Chen and colleagues in this issue of the journal (12). This study provides new data on strawberry powder in a high-risk group with dysplastic esophageal lesions.

In numerous preclinical studies of recent decades, berries have been shown to be protective against oral (13–16) and colon (17, 18) cancers, as well as against ulcerative colitis (19). Dietary black raspberries (5% and 10% of the diet) were chemopreventive in a hamster cheek pouch model of oral cancer (16). Further work showed that black raspberries inhibited azoxymethane-induced colon cancer in F344 rats (18). The role of berries in cancer prevention has been shown with lyophilized (freeze dried) black raspberries, blackberries, and strawberries in carcinogen-induced cancer of the rodent esophagus (20). In addition, lyophilized black raspberries have shown strong inhibitory effects against esophageal tumorigenesis in N-nitrosomethylbenzylamine (NMBA)-treated rats (21); the inhibitory effect correlated with inhibition of COX-2, inducible nitric oxide synthase (iNOS), c-Jun (22), and angiogenesis (23).

Dietary freeze-dried strawberries also have inhibited NMBA-induced esophageal tumorigenesis in rats (24, 25). Dietary administration of freeze-dried strawberries (10% of the diet) caused a significant reduction in tumor multiplicity and reduced O6-methylguanine levels in the esophageal DNA of animals (24). Strawberry polyphenols also attenuated ethanol-induced gastric lesions in rats (26). More recently, multiple berry types, including black raspberries, blueberries, strawberries, noni, acai, or wolfberries, have been tested in NMBA-induced rat esophageal cancer (27). Most of the berries at 5% of the diet provided protective effects against carcinogen-induced esophageal tumorigenesis and further decreased serum cytokines (27). Many small berries have been shown to have a similar chemopreventive potential, as might be expected on the basis of their similar compositions of key bioactive components.

Although comprehensive reviews of berries and cancer prevention summarize evidence that fruits and vegetables may reduce the risk for cancers of the oral cavity, esophagus, stomach, and colorectum (3, 28), a large-scale human intervention study showed only a weak association between the intake of fruits and vegetables and the reduced risk of cancer (29, 30). The few randomized clinical cancer prevention studies of fruits, vegetables, and natural product bioactives conducted to date include trials of berry bioactives in Barrett's esophagus, colon polyps, and oral cancer (31). Earlier work assessed the clinical chemopreventive effects of lyophilized black raspberries, with interim results showing that berries modulate markers of oxidative stress in Barrett's esophagus patients (32). A small human trial (11 subjects) designed to determine safety and tolerability found that 45 g of freeze-dried black raspberries daily were well tolerated, but less than 1% of the berries' anthocyanins (such as cyanidin-3-glucoside, cyanidin-3-sambubioside, cyanidin-3-rutinoside, and cyanidin-3 xylosylrutinoside) were absorbed and excreted in the urine (33). In another phase I pilot study, 20 patients received black raspberries (60 g per day) for 1 to 9 weeks (34). This study evaluated biomarkers, including the Wnt pathway, proliferation, apoptosis, and angiogenesis (34). In sum, various studies have provided strong evidence for the chemopreventive effects of many types of berries such as strawberries, black raspberries, and blueberries.

In considering an approach to exploit the translational value of extensive preclinical work, it is important to note that China has the highest incidence of squamous esophageal cancer in the world. Specifically, as discussed by Chen and colleagues (12), a number of prospective studies have identified areas of a high risk for esophageal cancer in the Taihang mountain region of China, including Linxian and Anyang (Henan Province), Chaoshan (Guangdong province) and Cixian (Hebei province). Although it is challenging to conduct randomized trials in developing regions, there is an unmet medical need for preventing squamous esophageal cancer that could be of immediate benefit for high-risk populations in these regions, and a precedent could be established for broader or more widespread applications.

On the basis of these considerations, particularly the high risk of esophageal cancer, and solid preclinical data on berries in a rat esophageal cancer model (20, 24, 25), Chen and colleagues have now investigated the chemopreventive role of strawberries in a high-risk group of patients with mild or moderate dysplastic lesions of the esophagus (12). They conducted a randomized, 2-arm phase II trial of freeze-dried strawberry powder for 6 months in 75 patients in a poor rural farming region of China with the highest incidence of esophageal cancer. A major reason for choosing strawberries (vs. other berries) likely was that they are the major berry grown in China. They evaluated several endpoints of intermediate biomarkers in mild and moderate dysplasia. Patients were randomized to 30 g/d or 60 g/d of strawberry powder; there was no placebo group. Biomarker analyses took place in samples obtained before and after treatment. Strawberries at 60 g/d produced highly significant reductions in the histologic grade of dysplastic lesions (the primary endpoint; P < 0.0001) and in study biomarkers (the inflammation markers iNOS, COX-2, phospho-NF-κB–p65, and phospho-S6 and the proliferation marker Ki-67), whereas 30 g/d produced little change in histologic grade, notwithstanding modest effects on some biomarkers. Previous work suggested that the risk for cancers of the oral cavity, esophagus, stomach, and colorectum may be reduced by diets including at least 400 g/d of total fruits and vegetables (3), which roughly correlates with 60 g/d of freeze-dried strawberry powder, the approximate equivalent of 600 g/d of fresh strawberries.

Strawberry powder had no apparent toxicity, even at the high dose of 60 g/d. The strawberry powder administered in this trial was dissolved in water. Ethanol extract of freeze-dried black raspberries has been investigated as poly(DL-lactic-co-glycolic acid) and poly(DL-lactic acid) loaded injectable millicylindrical implants for sustained delivery of anthocyanins; this formulation was found to be optimal for 1 month continuous delivery of black raspberry anthocyanins (35). A non-water formulation of strawberry powder also perhaps would provide better bioavailability or allow a lower effective dose. The importance of working out optimal formulations in early-phase clinical trials is highlighted by 2 recent reports, one involving resveratrol (36) and one involving indole analogs (37). With regard to global prevention, the lyophilized powder formulation of strawberries is not inexpensive and, if established to be effective, likely would require special measures to become available in developing regions.

This study had a few limitations in addition to the question of optimal formulation. For example, it examined only the few markers iNOS, COX-2, phospho-NF-κB–p65, phospho-S6, and Ki-67. Although the results are encouraging, berry bioactives and berry powders have been shown to regulate multiple pathways including NF-κB (IκBα, IκB kinase, iNOS, and COX-2), proliferating cell nuclear antigen, cell adhesion proteins (inter-cellular adhesion molecule 1), phosphoinositide 3-kinase/Akt, mitogen-activated protein kinase (extracellular signal-regulated kinase, c-Jun N-terminal kinase, and p38), angiogenesis (VEGF-1), and apoptosis (Bcl-2, p21, Bax, Bak, cytochrome c, and caspase-3; ref. 31). Multiple mechanisms could be responsible for strawberry activity because multiple bioactive components are present in berries. Therefore, investigation of more diverse biomarkers should be considered to more fully characterize the molecular mechanisms of the chemopreventive effects of strawberry powder.

Although Chen and colleagues conducted some analysis of the components from freeze-dried strawberries, another study limitation is not investigating the levels of key components in the serum, urine, or target tissues from patients who received the 2 different doses of freeze-dried strawberries. More important, it is not clear which components of strawberries contributed to the changes in biomarkers associated with the dysplastic lesions. Therefore, no specific correlation can be drawn from the strawberry intake and chemopreventive effects in this study. It would be of interest to investigate any association of patients who had histologic and biomarker responses with higher levels of key components of strawberries. Several bioactive phytochemicals commonly present in berries are possibly important, which helps in predicting that most berries, to a certain degree, may have a similar benefit in cancer prevention. These bioactive phytochemicals include anthocyanidins, proanthocyanidins, flavonoids and flavonols, hydroxybenzoic acid, hydroxycinnamic acid, stilbenoids, catechins, and ellagitannins (31, 38). Earlier work with black raspberries indicated that anthocyanins are key bioactive components responsible for preventing esophageal tumors in rats (39). Other studies found that berry ellagitannins did not effectively prevent rat esophagus tumors (40). Clearly, it will be important to identify which active components and molecular targets/mechanisms may be responsible for the efficacy of strawberries. Such work has recently been reported in regard to the epigallocatechin gallate component of green tea (41).

Chen and colleagues indicate that bioactivity guided fractionation is underway. On the basis of known responses, it is not especially clear which assay or assays will be utilized to identify active components. In addition, it is possible that multiple active principle components may be necessary to show efficacy (i.e., combination chemoprevention may be a more attractive option). Thus far, freeze-dried powder, extracts, or active components such as anthocyanins have been used for berry studies. In the future, it will be important to consider factors such as stability, toxicity, bioavailability, synthesis, and costs for human trials. Furthermore, it is essential that each berry preparation is standardized so that activity can be correlated with a specific content profile associated with the overall batch administered in a given study. Otherwise, interstudy, or even intrastudy, results could be confounded by different preparations going under the same name.

Thus, we pose the question, Is the best approach “Strawberry Fields Forever,” or would a novel formulation comprising one or more active principle components achieve greater efficacy with a more predicable outcome? Only time will tell, but Chen and colleagues are to be commended for showing an important “proof-of-principle” in clinical cancer prevention study. This randomized phase II trial in a high-risk group with dysplastic esophageal lesions has provided useful data on intermediate endpoints and biomarkers in regard to the chemopreventive effects of strawberries. The work signifies the overall importance of cancer prevention with dietary, nutritional, and natural products and lays the groundwork for future investigations.

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

  • Received November 11, 2011.
  • Revision received November 18, 2011.
  • Accepted November 22, 2011.
  • ©2012 American Association for Cancer Research.

References

  1. 1.↵
    1. Block G,
    2. Patterson B,
    3. Subar A
    . Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 1992;18:1–29.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Koushik A,
    2. Hunter DJ,
    3. Spiegelman D,
    4. Beeson WL,
    5. van den Brandt PA,
    6. Buring JE,
    7. et al.
    Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies. J Natl Cancer Inst 2007;99:1471–83.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Key TJ,
    2. Schatzkin A,
    3. Willett WC,
    4. Allen NE,
    5. Spencer EA,
    6. Travis RC
    . Diet, nutrition and the prevention of cancer. Public Health Nutr 2004;7:187–200.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Lippman SM,
    2. Klein EA,
    3. Goodman PJ,
    4. Lucia MS,
    5. Thompson IM,
    6. Ford LG,
    7. et al.
    Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009;301:39–51.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Klein EA,
    2. Thompson IM Jr,
    3. Tangen CM,
    4. Crowley JJ,
    5. Lucia MS,
    6. Goodman PJ,
    7. et al.
    Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011;306:1549–56.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Kensler TW,
    2. Chen JG,
    3. Egner PA,
    4. Fahey JW,
    5. Jacobson LP,
    6. Stephenson KK,
    7. et al.
    Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China. Cancer Epidemiol Biomarkers Prev 2005;14:2605–13.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Egner PA,
    2. Chen JG,
    3. Wang JB,
    4. Wu Y,
    5. Sun Y,
    6. Lu JH,
    7. et al.
    Bioavailability of sulforaphane from two broccoli sprout beverages: results of a short-term, cross-over clinical trial in Qidong, China. Cancer Prev Res 2011;4:384–95.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Kensler TW,
    2. Ng D,
    3. Carmella SG,
    4. Chen M,
    5. Jacobson LP,
    6. Munoz A,
    7. et al.
    Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, China. Carcinogenesis 2011 Nov 11. [Epub ahead of print].
  9. 9.↵
    1. Sun CL,
    2. Yuan JM,
    3. Lee MJ,
    4. Yang CS,
    5. Gao YT,
    6. Ross RK,
    7. et al.
    Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China. Carcinogenesis 2002;23:1497–503.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Yuan JM,
    2. Gao YT,
    3. Yang CS,
    4. Yu MC
    . Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the Shanghai Cohort Study. Int J Cancer 2007;120:1344–50.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Tsao AS,
    2. Liu D,
    3. Martin J,
    4. Tang XM,
    5. Lee JJ,
    6. El-Naggar AK,
    7. et al.
    Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res 2009;2:931–41.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Chen T,
    2. Yan F,
    3. Qian J,
    4. Guo M,
    5. Zhang H,
    6. Tang X,
    7. et al.
    Randomized clinical chemoprevention trial of lyophilized (freeze-dried) strawberries in patients with dysplastic precancerous lesions of the esophagus. Cancer Prev Res 2012;5:41–50.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Shumway BS,
    2. Kresty LA,
    3. Larsen PE,
    4. Zwick JC,
    5. Lu B,
    6. Fields HW,
    7. et al.
    Effects of a topically applied bioadhesive berry gel on loss of heterozygosity indices in premalignant oral lesions. Clin Cancer Res 2008;14:2421–30.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Mallery SR,
    2. Stoner GD,
    3. Larsen PE,
    4. Fields HW,
    5. Rodrigo KA,
    6. Schwartz SJ,
    7. et al.
    Formulation and in vitro and in vivo evaluation of a mucoadhesive gel containing freeze dried black raspberries: implications for oral cancer chemoprevention. Pharm Res 2007;24:728–37.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Mallery SR,
    2. Zwick JC,
    3. Pei P,
    4. Tong M,
    5. Larsen PE,
    6. Shumway BS,
    7. et al.
    Topical application of a bioadhesive black raspberry gel modulates gene expression and reduces cyclooxygenase 2 protein in human premalignant oral lesions. Cancer Res 2008;68:4945–57.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Casto BC,
    2. Kresty LA,
    3. Kraly CL,
    4. Pearl DK,
    5. Knobloch TJ,
    6. Schut HA,
    7. et al.
    Chemoprevention of oral cancer by black raspberries. Anticancer Res 2002;22:4005–15.
    OpenUrlPubMed
  17. 17.↵
    1. Bi X,
    2. Fang W,
    3. Wang LS,
    4. Stoner GD,
    5. Yang W
    . Black raspberries inhibit intestinal tumorigenesis in apc1638+/− and Muc2−/− mouse models of colorectal cancer. Cancer Prev Res 2010;3:1443–50.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Harris GK,
    2. Gupta A,
    3. Nines RG,
    4. Kresty LA,
    5. Habib SG,
    6. Frankel WL,
    7. et al.
    Effects of lyophilized black raspberries on azoxymethane-induced colon cancer and 8-hydroxy-2′-deoxyguanosine levels in the Fischer 344 rat. Nutr Cancer 2001;40:125–33.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Montrose DC,
    2. Horelik NA,
    3. Madigan JP,
    4. Stoner GD,
    5. Wang LS,
    6. Bruno RS,
    7. et al.
    Anti-inflammatory effects of freeze-dried black raspberry powder in ulcerative colitis. Carcinogenesis 2011;32:343–50.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Stoner GD,
    2. Chen T,
    3. Kresty LA,
    4. Aziz RM,
    5. Reinemann T,
    6. Nines R
    . Protection against esophageal cancer in rodents with lyophilized berries: potential mechanisms. Nutr Cancer 2006;54:33–46.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Kresty LA,
    2. Morse MA,
    3. Morgan C,
    4. Carlton PS,
    5. Lu J,
    6. Gupta A,
    7. et al.
    Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Res 2001;61:6112–9.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Chen T,
    2. Hwang H,
    3. Rose ME,
    4. Nines RG,
    5. Stoner GD
    . Chemopreventive properties of black raspberries in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis: down-regulation of cyclooxygenase-2, inducible nitric oxide synthase, and c-Jun. Cancer Res 2006;66:2853–9.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Chen T,
    2. Rose ME,
    3. Hwang H,
    4. Nines RG,
    5. Stoner GD
    . Black raspberries inhibit N-nitrosomethylbenzylamine (NMBA)-induced angiogenesis in rat esophagus parallel to the suppression of COX-2 and iNOS. Carcinogenesis 2006;27:2301–7.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Carlton PS,
    2. Kresty LA,
    3. Siglin JC,
    4. Morse MA,
    5. Lu J,
    6. Morgan C,
    7. et al.
    Inhibition of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus by dietary freeze-dried strawberries. Carcinogenesis 2001;22:441–6.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Stoner GD,
    2. Kresty LA,
    3. Carlton PS,
    4. Siglin JC,
    5. Morse MA
    . Isothiocyanates and freeze-dried strawberries as inhibitors of esophageal cancer. Toxicol Sci 1999;52:95–100.
    OpenUrlAbstract
  26. 26.↵
    1. Alvarez-Suarez JM,
    2. Dekanski D,
    3. Ristic S,
    4. Radonjic NV,
    5. Petronijevic ND,
    6. Giampieri F,
    7. et al.
    Strawberry polyphenols attenuate ethanol-induced gastric lesions in rats by activation of antioxidant enzymes and attenuation of MDA increase. PLoS One 2011;6:e25878.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Stoner GD,
    2. Wang LS,
    3. Seguin C,
    4. Rocha C,
    5. Stoner K,
    6. Chiu S,
    7. et al.
    Multiple berry types prevent N-nitrosomethylbenzylamine-induced esophageal cancer in rats. Pharm Res 2010;27:1138–45.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Stoner GD
    . Foodstuffs for preventing cancer: the preclinical and clinical development of berries. Cancer Prev Res 2009;2:187–94.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Boffetta P,
    2. Couto E,
    3. Wichmann J,
    4. Ferrari P,
    5. Trichopoulos D,
    6. Bueno-de-Mesquita HB,
    7. et al.
    Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2010;102:529–37.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Aune D,
    2. Lau R,
    3. Chan DS,
    4. Vieira R,
    5. Greenwood DC,
    6. Kampman E,
    7. et al.
    Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies. Gastroenterology 2011;141:106–18.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Stoner GD,
    2. Wang LS,
    3. Casto BC
    . Laboratory and clinical studies of cancer chemoprevention by antioxidants in berries. Carcinogenesis 2008;29:1665–74.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Kresty LA,
    2. Frankel WL,
    3. Hammond CD,
    4. Baird ME,
    5. Mele JM,
    6. Stoner GD,
    7. et al.
    Transitioning from preclinical to clinical chemopreventive assessments of lyophilized black raspberries: interim results show berries modulate markers of oxidative stress in Barrett's esophagus patients. Nutr Cancer 2006;54:148–56.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Stoner GD,
    2. Sardo C,
    3. Apseloff G,
    4. Mullet D,
    5. Wargo W,
    6. Pound V,
    7. et al.
    Pharmacokinetics of anthocyanins and ellagic acid in healthy volunteers fed freeze-dried black raspberries daily for 7 days. J Clin Pharmacol 2005;45:1153–64.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Wang LS,
    2. Arnold M,
    3. Huang YW,
    4. Sardo C,
    5. Seguin C,
    6. Martin E,
    7. et al.
    Modulation of genetic and epigenetic biomarkers of colorectal cancer in humans by black raspberries: a phase I pilot study. Clin Cancer Res 2011;17:598–610.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    1. Desai KG,
    2. Olsen KF,
    3. Mallery SR,
    4. Stoner GD,
    5. Schwendeman SP
    . Formulation and in vitro-in vivo evaluation of black raspberry extract-loaded PLGA/PLA injectable millicylindrical implants for sustained delivery of chemopreventive anthocyanins. Pharm Res 2010;27:628–43.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Howells LM,
    2. Berry DP,
    3. Elliott PJ,
    4. Jacobson EW,
    5. Hoffmann E,
    6. Hegarty B,
    7. et al.
    Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases–safety, pharmacokinetics, and pharmacodynamics. Cancer Prev Res 2011;4:1419–25.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Reid JM,
    2. Walden CA,
    3. Qin R,
    4. Ziegler KL,
    5. Haslam JL,
    6. Rajewski RA,
    7. et al.
    Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668. Cancer Prev Res 2011;4:347–53.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Hannum SM
    . Potential impact of strawberries on human health: a review of the science. Crit Rev Food Sci Nutr 2004;44:1–17.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Wang LS,
    2. Hecht SS,
    3. Carmella SG,
    4. Yu N,
    5. Larue B,
    6. Henry C,
    7. et al.
    Anthocyanins in black raspberries prevent esophageal tumors in rats. Cancer Prev Res 2009;2:84–93.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. Wang LS,
    2. Hecht S,
    3. Carmella S,
    4. Seguin C,
    5. Rocha C,
    6. Yu N,
    7. et al.
    Berry ellagitannins may not be sufficient for prevention of tumors in the rodent esophagus. J Agric Food Chem 2010;58:3992–5.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Urusova DV,
    2. Shim JH,
    3. Kim DJ,
    4. Jung SK,
    5. Zykova TA,
    6. Carper A,
    7. et al.
    Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1. Cancer Prev Res 2011;4:1366–77.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Cancer Prevention Research: 5 (1)
January 2012
Volume 5, Issue 1
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Prevention Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Strawberry Fields Forever?
(Your Name) has forwarded a page to you from Cancer Prevention Research
(Your Name) thought you would be interested in this article in Cancer Prevention Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Strawberry Fields Forever?
Nanjoo Suh and John M. Pezzuto
Cancer Prev Res January 1 2012 (5) (1) 30-33; DOI: 10.1158/1940-6207.CAPR-11-0534

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Strawberry Fields Forever?
Nanjoo Suh and John M. Pezzuto
Cancer Prev Res January 1 2012 (5) (1) 30-33; DOI: 10.1158/1940-6207.CAPR-11-0534
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Disclosure of Potential Conflicts of Interest
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • The Case for a Pre-Cancer Genome Atlas (PCGA)
  • HPV-Positive Oropharyngeal Cancers
  • Indeterminate Pulmonary Nodules
Show more Perspective
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Prevention Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Prevention Research
eISSN: 1940-6215
ISSN: 1940-6207

Advertisement